Drug-Related problems and PIs for patients with COVID-19-positive and COVID-19-negative statuses
| PIs | Addition | Stop | Substitution | Biological/drug follow-up | Optimal administration | Dosage adaptation | Total | |||||||
| COVID-19 status | + | – | + | – | + | – | + | – | + | – | + | – | + | – |
| Non-conformity to guidelines | 19 | 17 | 6 | 1 | 2 | 27 | 18 | |||||||
| Drug follow-up | 2 | 3 | 2 | 3 | ||||||||||
| Indication not treated (forgetting a drug) | 16 | 10 | 16 | 10 | ||||||||||
| Underdosage | 1 | 1 | 11 | 16 | 12 | 17 | ||||||||
| Overdosage | 5 | 3 | 1 | 12 | 19 | 17 | 23 | |||||||
| Drug without indication | 6 | 2 | 6 | 2 | ||||||||||
| Side effect | 1 | 1 | 2 | 1 | 3 | 2 | ||||||||
| Inappropriate administration | 1 | 1 | 18 | 5 | 1 | 18 | 8 | |||||||
| Drug–drug interactions | 2 | 1 | 1 | 3 | 1 | |||||||||
| Total | 16 | 10 | 32 | 24 | 8 | 3 | 4 | 5 | 19 | 6 | 25 | 36 | 104 | 84 |
PI, pharmaceutical intervention.